Filters

Jill M Ellis, Hooi Kuan Tan, Ruth E Gilbert, David P R Muller, William Henley, Robert Moy, Rachel Pumphrey, Cornelius Ani, Sarah Davies, Vanessa Edwards, Heather Green, Alison Salt, Stuart Logan

BMJ (Clinical research ed.) 2008;336(7644):594-7

Free Full Text

Abstract

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.

R E Frye, J Slattery, L Delhey, B Furgerson, T Strickland, M Tippett, A Sailey, R Wynne, S Rose, S Melnyk, S Jill James, J M Sequeira, E V Quadros

Molecular psychiatry 2019;23(2):247-256

Free Full Text

Abstract

Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.

Dale M Needham, Elizabeth Colantuoni, Victor D Dinglas, Catherine L Hough, Amy W Wozniak, James C Jackson, Peter E Morris, Pedro A Mendez-Tellez, E Wesley Ely, Ramona O Hopkins

The Lancet. Respiratory medicine 2017;4(3):203-12

Free Full Text

Abstract

Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

Toni S Pearson, Cigdem Akman, Veronica J Hinton, Kristin Engelstad, Darryl C De Vivo

Current neurology and neuroscience reports 2013;13(4):342

Full Text

Abstract

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya, James Poysky, Frederic Shapiro, Jean Tomezsko, Carolyn Constantin

The Lancet. Neurology 2010;9(2):177-89

Full Text

Abstract

Examining the language and behavioural profile in FTD and ALS-FTD.

Jennifer A Saxon, Jennifer C Thompson, Matthew Jones, Jennifer M Harris, Anna Mt Richardson, Tobias Langheinrich, David Neary, David Ma Mann, Julie S Snowden

Journal of neurology, neurosurgery, and psychiatry 2017;88(8):675-680

Free Full Text

Abstract

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.

Patrizia Mecocci, Anna Bladström, Karina Stender

International journal of geriatric psychiatry 2010;24(5):532-8

Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Language Disorders""[mesh_terms]

The utility of functional magnetic resonance imaging in epilepsy and language.

Childhood disintegrative disorder and autism spectrum disorder: a systematic review.

Neurodevelopmental outcomes after prenatal exposure to lamotrigine monotherapy in women with epilepsy: a systematic review and meta-analysis.

Alzheimer's Disease and Autistic Spectrum Disorder: Is there any Association?

Alzheimer's disease and language impairments: social intervention and medical treatment.

Functional magnetic resonance imaging of language in epilepsy.

A randomised, controlled study of dietary intervention in autistic syndromes.

Fluctuations in clinical symptoms with changes in serum 25(OH) vitamin D levels in autistic children: Three cases report.

Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.

Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.

Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Examining the language and behavioural profile in FTD and ALS-FTD.

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.

Results for
""Language Disorders""[mesh_terms]